Serum amino acid alterations in hyperuricemia: potential targets for renal disease prevention
Authors:
Open Access
- 18 February 2025
- journal article
- research article
- Published by Springer Nature in Amino Acids
- Vol. 57 (1) , 1-15
Abstract
Observational studies have linked uric acid (UA) levels and kidney disease to amino acid homeostasis, but the causal relationship is unclear. This study aims to determine if elevated UA affects amino acid levels and whether amino acids mediate this relationship, focusing on the causal links between UA, circulating amino acids, and kidney disease. Methods: This study utilized Uox-KO mice as a hyperuricemia model, assessed renal injury through blood biochemistry and pathology, analyzed serum amino acid changes via targeted amino acidomics, and employed Mendelian randomization to investigate the causal links between uric acid, amino acids, and renal disease. Results: Hyperuricemia Uox-KO mice have significantly higher serum UA and renal impairment markers, with histopathological analysis showing extensive renal tissue damage. Changes in amino acid balance were found in the mice's serum, with key metabolites like alanine, isoleucine, leucine, aspartic acid, cysteine, glutamate, and glycine potentially influencing UA pathophysiology. Genetically predicted UA was positively correlated with chronic renal failure (CRF) and blood urea nitrogen(BUN) levels and negatively with serum cystatin C (eGFRcys) and serum creatinine (eGFRcrea). Alanine (Ala) mediated the effect of UA on elevated CRF and BUN risk, accounting for 4.5% of the UA-CRF relationship and 14.4% of the UA-BUN association. Conclusion: In hyperuricemia mice, serum amino acids undergo metabolic changes. Genetically predicted UA levels are positively linked to CRF and BUN, but negatively linked to eGFRcys and eGFRcrea. Ala mediates UA's effect on CRF and BUN risk, indicating Ala could be a target for preventing renal diseases caused by hyperuricemia. Graphical abstractKeywords
All Related Versions
This publication has 46 references indexed in Scilit:
- Uric acid in metabolic syndrome: Does uric acid have a definitive role?European Journal of Internal Medicine, 2022
- Mediators of the association between educational attainment and type 2 diabetes mellitus: a two-step multivariable Mendelian randomisation studyDiabetologia, 2022
- Mendelian randomisation for mediation analysis: current methods and challenges for implementationEuropean Journal of Epidemiology, 2021
- Causal links between major depressive disorder and insomnia: A Mendelian randomisation studyGene, 2021
- Altered metabolic profiles and biomarkers associated with astragaloside IV-mediated protection against cisplatin-induced acute kidney injury in rats: An HPLC-TOF/MS-based untargeted metabolomics studyBiochemical Pharmacology, 2021
- Hyperuricaemia and gout in cardiovascular, metabolic and kidney diseaseEuropean Journal of Internal Medicine, 2020
- Plasma profiling of amino acids distinguishes acute gout from asymptomatic hyperuricemiaAmino Acids, 2018
- Uric acid induces oxidative stress via an activation of the renin–angiotensin system in 3T3-L1 adipocytesEndocrine, 2014
- Transport of Amino Acids in the Kidney2014
- 13C-enrichment at carbons 8 and 2 of uric acid after 13C-labeled folate dose in manBiochemical and Biophysical Research Communications, 2007